Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

The complaint claims that the state illegally changed rules regarding income eligibility thresholds for the AIDS Drug ...

HIV/AIDS activists heralded the approval of a new twice-yearly pre-exposure prophylaxis (PrEP) medication last year, but these celebrations were tempered by insurers’ reluctance to cover its ...

The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead ...

Scientists say research into a vaccine for HIV is further along than it’s ever been.But Trump administration cuts to ...

The devastating aids epidemic has claimed hundreds of thousands of lives—did you know that a sick chimpanzee is part of what ...

Still, the medications in the latest round of negotiations — which now includes “Part B” drugs given in doctors offices — ...

A trial was about to launch for a vaccine that would ward off the HIV virus. It would be an incredible breakthrough. Then it looked as if it would be over before it started.

The tool can be used to find providers that offer HIV testing and medications that prevent the virus, which causes AIDS.

Andrew Spieldenner, executive director of MPACT Global, is one of The Advocate's 2026 Amazing People with HIV.

The debate over Florida’s HIV medication cuts is intensifying as advocates, lawmakers, and healthcare professionals push back ...